Satoshi Ueno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Satoshi Ueno has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Hatanaka
1 shared publication- Hiroshi Kataoka
Department of Neurology, Nara Medical University, Nara, Japan
1 shared publication - Hisao Shimizu
Takeda Pharmaceutical Company Ltd, Kanagawa, 251-8555, Japan
1 shared publication - Hitoshi Nakayama
Laboratory of Biochemistry, Faculty of Health Care and Nursing Juntendo University Chiba Japan
1 shared publication - Hong Zhang
College of Life Sciences, Huaibei Normal University, Huaibei 235000, China
1 shared publication Kohtaro Kusaka
Division of Insect Sciences, National Institute of Agrobiological Sciences
1 shared publication
Latest Publications
- Open Access
- 23 December 2008
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 72 (12) , 3281-3284
Anionic C-Terminal Proregion of Nematode Antimicrobial Peptide Cecropin P4 Precursor Inhibits Antimicrobial Activity of the Mature Peptide
Recently, an anionic proregion was found to be conserved at the C terminus of the antimicrobial peptide, nematode cecropin. Our results suggest that the antimicrobial activity of mature peptide is suppressed by the proregion in its precursor and is released from inhibition after processing. Inhibition is not likely to be due to direct suppression of membrane disruption.
- 23 December 2008
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 72 (12) , 3281-3284
Open AccessAnionic C-Terminal Proregion of Nematode Antimicrobial Peptide Cecropin P4 Precursor Inhibits Antimicrobial Activity of the Mature Peptide
Recently, an anionic proregion was found to be conserved at the C terminus of the antimicrobial peptide, nematode cecropin. Our results suggest that the antimicrobial activity of mature peptide is suppressed by the proregion in its precursor and is released from inhibition after processing. Inhibition is not likely to be due to direct suppression of membrane disruption.
- 22 November 2006
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 109 (3) , 277-278
Interferon causes no myasthenia in a seropositive patient with multiple sclerosis
- 22 November 2006
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 109 (3) , 277-278
Interferon causes no myasthenia in a seropositive patient with multiple sclerosis
- Open Access
- 1 April 2000
- Published by Wiley in Journal of Neurochemistry
- Vol. 74 (4) , 1346-1354
Regulation of α3 Nicotinic Acetylcholine Receptor Subunit mRNA Levels by Nerve Growth Factor and Cyclic AMP in PC12 Cells
To investigate the effects of nerve growth factor (NGF) and cyclic AMP (cAMP) on the level of the nicotinic acetylcholine receptor subunit α3 mRNA, we used PC12h cells, PC12 cells expressing dominant‐negative Ras protein, and the parental PC12 cells. PC12h cells have NGF‐responsive tyrosine hydroxylase activity. Expression of dominant‐negative Ras protein prevents the signaling through the Ras‐mitogen‐activated protein kinase cascade. The morphological changes of the parental PC12 cells in response to NGF and 8‐(4‐chlorophenylthio)adenosine 3′,5′‐cyclic monophosphate (CPTcAMP), a cell‐penetrating cAMP analogue, were similar to those of PC12h cells. NGF up‐regulated the α3 mRNA level in PC12h cells and down‐regulated the α3 mRNA level in the parental PC12 cells. Expression of dominant‐negative Ras protein and an inhibitor of mitogen‐activated protein kinase kinase inhibited the effects of NGF on α3 mRNA level. CPTcAMP down‐regulated the α3 mRNA level in all three PC12 cell lines. An inhibitor of protein kinase A inhibited the CPTcAMP‐induced down‐regulation of α3 mRNA. The α3 mRNA down‐regulation required prolonged treatment with CPTcAMP even after cAMP response element binding protein phosphorylation was decreased. Membrane depolarization with high K+ had no effect on the α3 mRNA level in PC12h cells. Based on these results, we propose that at least two unknown effectors regulate α3 mRNA levels in PC12 cells.
- 1 April 2000
- Published by Wiley in Journal of Neurochemistry
- Vol. 74 (4) , 1346-1354
Open AccessRegulation of α3 Nicotinic Acetylcholine Receptor Subunit mRNA Levels by Nerve Growth Factor and Cyclic AMP in PC12 Cells
To investigate the effects of nerve growth factor (NGF) and cyclic AMP (cAMP) on the level of the nicotinic acetylcholine receptor subunit α3 mRNA, we used PC12h cells, PC12 cells expressing dominant‐negative Ras protein, and the parental PC12 cells. PC12h cells have NGF‐responsive tyrosine hydroxylase activity. Expression of dominant‐negative Ras protein prevents the signaling through the Ras‐mitogen‐activated protein kinase cascade. The morphological changes of the parental PC12 cells in response to NGF and 8‐(4‐chlorophenylthio)adenosine 3′,5′‐cyclic monophosphate (CPTcAMP), a cell‐penetrating cAMP analogue, were similar to those of PC12h cells. NGF up‐regulated the α3 mRNA level in PC12h cells and down‐regulated the α3 mRNA level in the parental PC12 cells. Expression of dominant‐negative Ras protein and an inhibitor of mitogen‐activated protein kinase kinase inhibited the effects of NGF on α3 mRNA level. CPTcAMP down‐regulated the α3 mRNA level in all three PC12 cell lines. An inhibitor of protein kinase A inhibited the CPTcAMP‐induced down‐regulation of α3 mRNA. The α3 mRNA down‐regulation required prolonged treatment with CPTcAMP even after cAMP response element binding protein phosphorylation was decreased. Membrane depolarization with high K+ had no effect on the α3 mRNA level in PC12h cells. Based on these results, we propose that at least two unknown effectors regulate α3 mRNA levels in PC12 cells.
- 1 February 1996
- Published by Wolters Kluwer Health in Neurology
- Vol. 46 (2) , 571-574
Japanese triplets with cerebrotendinous xanthomatosis are homozygous for a mutant gene coding for the sterol 27-hydroxylase (Arg441Trp)
We present the first case of triplets with cerebrotendinous xanthomatosis (CTX).A C-to-T base change identified in the genomic DNA and cDNA encoding the sterol 27-hydroxylase led to replacement of arginine by tryptophan at position 441 (Arg441Trp) in the triplets. The triplets were homozygous and their mother was heterozygous for this mutant gene. The triplets exhibited an identical phenotypic expression, which was different from that of a sporadic CTX case with the same mutation.
- 1 February 1996
- Published by Wolters Kluwer Health in Neurology
- Vol. 46 (2) , 571-574
Japanese triplets with cerebrotendinous xanthomatosis are homozygous for a mutant gene coding for the sterol 27-hydroxylase (Arg441Trp)
We present the first case of triplets with cerebrotendinous xanthomatosis (CTX).A C-to-T base change identified in the genomic DNA and cDNA encoding the sterol 27-hydroxylase led to replacement of arginine by tryptophan at position 441 (Arg441Trp) in the triplets. The triplets were homozygous and their mother was heterozygous for this mutant gene. The triplets exhibited an identical phenotypic expression, which was different from that of a sporadic CTX case with the same mutation.